Golden, CO, United States of America

Floyd Taub

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Floyd Taub: Innovator in Immune Modulation**

Introduction

Floyd Taub, an accomplished inventor based in Golden, Colorado, is recognized for his significant contributions to the field of immune modulation. With a focus on innovative therapies for cancer treatment, Taub has developed methods that utilize specific compounds to enhance immune responses against malignancies.

Latest Patents

Floyd Taub holds a patent for "Beta-alethine, immune modulators, and uses thereof." This groundbreaking patent outlines methods, kits, and compositions that include β-alethine alongside various immune modulators. The invention particularly emphasizes its applications in cancer treatment, aiming to provide novel therapeutic strategies for combating the disease.

Career Highlights

Throughout his career, Taub has been associated with prominent organizations, including Aximmune, Inc., and the Colorado State University Research Foundation. His work at these institutions has been pivotal in developing new approaches to immune therapy, highlighting his commitment to advancing medical science.

Collaborations

Floyd Taub has collaborated closely with Amanda Guth, leveraging their combined expertise to enhance their research and development efforts in immunology. Through these partnerships, they have worked to refine and expand the applications of innovative treatments that aim to improve patient outcomes.

Conclusion

With a patent portfolio that reflects his dedication to innovation, Floyd Taub continues to be a driving force in the realm of immunology. His work not only contributes to the scientific community but also holds the potential to improve the lives of countless individuals facing cancer. As research in this area progresses, Taub's contributions will undoubtedly play a vital role in shaping the future of immune modulatory therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…